http://www.translate.bio
Translate Bio, Inc. Company Intro
Translate Bio is an mRNA therapeutics company developing potentially transformative medicines to treat diseases caused by protein or gene dysfunction.
Industry
Healthcare
Translate Bio, Inc. Headquaters
29 Hartwell Avenue
Lexington,02421
United States
Translate Bio, Inc. Share price
15 Jan 2021 02:39 GMT
$23.00
0.04 (0.17 %)
Translate Bio, Inc. Market cap
$1.736 B
WMC RANKING
2021
Translate Bio, Inc. # 181
BiotechnologyLatest Translate Bio, Inc. News
07 Jan 2021
Global Ornithine-Transcarbamylase Deficiency Sales Market (2020) to Witness Huge Growth by 2026 | Lucane Pharma SA, PhaseRx Inc, Promethera Biosciences SA, Selecta Biosciences Inc, Translate Bio Inc
Selecta Biosciences Inc; Translate Bio Inc; Ultragenyx Pharmaceutical Inc; Unicyte AG. Get Sample PDF Copy (including COVID19 Impact Analysis, full TOC, ...
07 Jan 2021
Global Ornithine-Transcarbamylase Deficiency Sales Market (2020) to Witness Huge Growth by 2026 | Lucane Pharma SA, PhaseRx Inc, Promethera Biosciences SA, Selecta Biosciences Inc, Translate Bio Inc
Selecta Biosciences Inc; Translate Bio Inc; Ultragenyx Pharmaceutical Inc; Unicyte AG. Get Sample PDF Copy (including COVID19 Impact Analysis, full TOC, ...
07 Jan 2021
Global Ornithine-Transcarbamylase Deficiency Sales Market (2020) to Witness Huge Growth by 2026 | Lucane Pharma SA, PhaseRx Inc, Promethera Biosciences SA, Selecta Biosciences Inc, Translate Bio Inc
Selecta Biosciences Inc; Translate Bio Inc; Ultragenyx Pharmaceutical Inc; Unicyte AG. Get Sample PDF Copy (including COVID19 Impact Analysis, full TOC, ...
WMC Market Score
WMC Market to Revenue Score
Translate Bio, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Translate Bio, Inc. | USD | $7,804 | $105,001 | $-113,293 | $17,360B | 181 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $552,640B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $342,630B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $588,000B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $279,490B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Translate Bio, Inc. Social Followers vs Top 4 Industry Competitors
Translate Bio, Inc. Post vs Top 4 Industry Competitors
Translate Bio, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Translate Bio, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Translate Bio, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Translate Bio, Inc. | 0.08 | 2.80 | 26.42 | 0 | 0 | 0 | 15.00 |
| Regeneron Pharmaceuticals, Inc. | 100 | 65.98 | 28.72 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.08 | 100 | 60 | 0 | 0 | 90.49 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.81 | 86 | 0 | 0 | 99.97 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
